The effects of buprenorphine depot implants on patient sleep and quality of life: findings from a mixed-methods pilot trial

References

• Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. 2003. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 26(3):342–392.
   PubMed Web of Science ®Google Scholar
• Boyer EW, McCance-Katz EF, Marcus S. 2010. Methadone and buprenorphine toxicity in children. Am J Addict. 19(1):89–95.
   PubMed Web of Science ®Google Scholar
• Casola PG, Daiter J, Goldsmith RJ, Daiter J, Varenbut M. 2006. Sleep in the substance-using population. Psychiatr Ann. 36(6):841–846.
   Google Scholar
• Charmaz K. 2014. Constructing grounded theory. London (UK): SAGE.
   Google Scholar
• Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. 1992. Automatic sleep/wake identification from wrist activity. Sleep. 15(5):461–469.
   PubMed Web of Science ®Google Scholar
• Dursun SM, Patel JK, Burke JG, Revely MA. 1999. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci. 24:333–337.
   PubMed Web of Science ®Google Scholar
• Falck RS, Landry GJ, Brazendale K, Liu-Ambrose T. 2017. Measuring physical activity in older adults using motion watch 8 actigraphy: how many days are needed? J Aging Phys Act. 25(1):51–57.
   PubMed Web of Science ®Google Scholar
• Freedson PS, Melanson E, Sirard J. 1998. Calibration of the computer science and applications, Inc. accelerometer. Med Sci Sports Exerc. 30(5):777–781.
   PubMed Web of Science ®Google Scholar
• Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O'Grady KE, Olsen YK, Mitchell SG. 2013. Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. Am J Addict. 22(3):285–291.
   PubMed Web of Science ®Google Scholar
• Harris S. 2015. To be free and normal: Addiction, governance, and the therapeutics of Buprenorphine. Med Anthropol Q. 29(4):512–530.
   PubMed Web of Science ®Google Scholar
• Hartwell EE, Pfeifer JG, McCauley JL, Moran-Santa Maria M, Back SE. 2014. Sleep disturbances and pain among individuals with prescription opioid dependence. Addict Behav. 39(10):1537–1542.
   PubMed Web of Science ®Google Scholar
• Hedegaard H, Warner M, Minino AM. 2017. Drug Overdose Deaths in the United States, 1999-2015. NCHS Data Brief 20171-8.
   Google Scholar
• Iyer S, Banks N, Roy M-A, Tibbo P, Williams R, Manchanda R, Chue P, Malla A. 2013. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I – Patient perspectives. Can J Psychiatry. 58(5_suppl):14–22.
   Web of Science ®Google Scholar
• Keane CA, Kelly PJ, Magee CA, Callister R, Baker A, Deane FP. 2016. Exploration of sedentary behavior in residential substance abuse populations: results from an intervention study. Subst Use Misuse. 51(10):1363–1378.
   PubMed Web of Science ®Google Scholar
• Krystal AD, Edinger JD. 2008. Measuring sleep quality. Sleep Med. 9(Suppl 1):S10–S17.
   PubMed Web of Science ®Google Scholar
• Lindenmayer JP, Jarboe K, Bossie CA, Zhu Y, Mehnert A, Lasser R. 2005. Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone. Int Clin Psychopharmacol. 20(4):213–221.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. 2009. Methadone maintenance therapy vs no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. (3):CD002209.
   Google Scholar
• Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. 2004. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 27(7):1255–1273.
   PubMed Web of Science ®Google Scholar
• Pjrek E, Frey R, Naderi-Heiden A, Strnad A, Kowarik A, Kasper S, Winkler D. 2012. Actigraphic measurements in opioid detoxification with methadone or buprenorphine. J Clin Psychopharmacol. 32(1):75–82.
   PubMed Web of Science ®Google Scholar
• Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ. 2016. Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial. JAMA. 316(3):282–290.
   PubMed Web of Science ®Google Scholar
• Sadeh A. 2011. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev. 15(4):259–267.
   PubMed Web of Science ®Google Scholar
• Sherrill DL, Kotchou K, Quan SF. 1998. Association of physical activity and human sleep disorders. Arch Intern Med. 158(17):1894–1898.
   PubMedGoogle Scholar
• Troiano RP. 2007. Large-scale applications of accelerometers: new frontiers and new questions. Med Sci Sports Exerc. 39(9):1501.
   PubMed Web of Science ®Google Scholar
• Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Cocker K, Giles-Corti B, Hatano Y, Inoue S, Matsudo SM, Mutrie N, et al. 2011. How many steps/day are enough? For adults. Int J Behav Nutr Phys Act. 8(1):79.
   PubMed Web of Science ®Google Scholar
• Turner CW, Lewis JR, Nielsen J. 2006. Determining usability test sample size. In: Waldemar K, editor. International encyclopedia of ergonomics and human factors, 2nd ed. Vol 3. Boca Raton, FL: CRC Press; p. 3084–3088.
   Google Scholar
• Vallieres A, Morin CM. 2003. Actigraphy in the assessment of insomnia. Sleep. 26(7):902–906.
   PubMed Web of Science ®Google Scholar
• Van Den Berg JF, Van Rooij FJA, Vos H, Tulen JHM, Hofman A, Miedema HME, Neven AK, Tiemeier H. 2008. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res. 17(3):295–302.
   PubMed Web of Science ®Google Scholar
• Weinstock J, Barry D, Petry NM. 2008. Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders. Addict Behav. 33(8):1072–1075.
   PubMed Web of Science ®Google Scholar
• Wilson SJ, Rich AS, Rich NC, Potokar J, Nutt DJ. 2004. Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia. Int Clin Psychopharmacol. 19(2):77.
   PubMed Web of Science ®Google Scholar
• Wright N, D'Agnone O, Krajci P, Littlewood R, Alho H, Reimer J, Roncero C, Somaini L, Maremmani I. 2016. Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience. J Public Health. 38(3):e368–e374.
   Google Scholar
• Yarlas A, Miller K, Wen W, Lynch SY, Ripa SR, Pergolizzi JV, Raffa RB. 2016. Buprenorphine transdermal system improves sleep quality and reduces sleep disturbance in patients with Moderate-to-Severe chronic low back pain: results from two randomized controlled trials. Pain Pract. 16(3):345–358.
   PubMed Web of Science ®Google Scholar
• Zheng WH, Wakim RJ, Geary RC, Lander LR, Wen SJ, Xiao MC, Sullivan CR. 2016. Self-reported sleep improvement in buprenorphine MAT (medication assisted treatment) population. Austin J Drug Abuse Addict. 3.
   PubMedGoogle Scholar
• Zschucke E, Heinz A, Ströhle A. 2012. Exercise and physical activity in the therapy of substance use disorders. Sci World J. 2012:901741.
   Web of Science ®Google Scholar